Back to Search
Start Over
[Stage I seminoma and radiotherapy: to bury it or not?].
- Source :
-
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2008 Dec; Vol. 12 (8), pp. 842-7. Date of Electronic Publication: 2008 Aug 28. - Publication Year :
- 2008
-
Abstract
- Postorchidectomy management of stage I testis seminoma has evolved for many years. Three treatment options should be discussed after surgery. Surveillance tends toward taking a more significant place to avoid overtreatment, adjuvant chemotherapy with carboplatin has demonstrated its efficiency, and for some, preventive radiotherapy, the historical reference treatment, is losing momentum. Whatever the chosen orientation, long-term prognosis is excellent with overall survival closed to 100%. In this context, this review underlines the advantages and the drawbacks of the three attitudes but also the unknowns relative to each. Indeed, their knowledge is crucial for informing clearly and with an objective way. Without gold-standard, but with three therapeutic options available, informing our patients is the key so they make an informed choice in dialogue with the oncologist.
- Subjects :
- Antineoplastic Agents therapeutic use
Carboplatin therapeutic use
Combined Modality Therapy
Humans
Male
Neoplasm Staging
Seminoma drug therapy
Seminoma mortality
Seminoma surgery
Survival Rate
Testicular Neoplasms drug therapy
Testicular Neoplasms mortality
Testicular Neoplasms pathology
Testicular Neoplasms surgery
Orchiectomy
Seminoma pathology
Seminoma radiotherapy
Testicular Neoplasms radiotherapy
Subjects
Details
- Language :
- French
- ISSN :
- 1278-3218
- Volume :
- 12
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
- Publication Type :
- Academic Journal
- Accession number :
- 18760650
- Full Text :
- https://doi.org/10.1016/j.canrad.2008.07.015